Chemotherapy‐associated changes in ³¹P MRS spectra of sera from patients with multiple myeloma

Abstract

31P NMR spectra were obtained from sera of 22 healthy volunteers and 20 patients with multiple myeloma at the time of diagnosis and repeated up to five times during therapy. All spectra consisted of a Pi peak (used as a reference peak) and two peaks from phospholipids (PL): one peak due to phosphatidylethanolamine and sphingomyelin (PE + SM) and a second peak due to phosphatidylcholine (PC). Prior to therapy, peak intensities of the phospholipids were low relative to Pi. During therapy leading to remission, the resonance from PL progressively increased to approximate the spectral pattern seen in normal sera. By contrast, in non-responders an opposite trend was noted: the intensities of the phospholipid peaks became progressively reduced or remained unchanged. Long-term follow-up studies showed a good correlation between this 31P MRS evaluation of sera and the response of the disease to the therapy. In addition to the correlation with tumor response, our studies also show significant correlations between area, intensities of peaks of PE + SM, PC, and the concentrations of high-density lipoprotein (HDL) (correlation coefficients 0.46, 0.43, 0.59, respectively; p < 0.001). We found that the concentration of HDL in serum of patients with multiple myeloma was significantly reduced. In individuals responding to therapy HDL levels increased to the point where there were no statistically significant differences between them and healthy volunteers. In patients not responding to therapy, HDL concentration did not increase.(ABSTRACT TRUNCATED AT 250 WORDS)

Metabonomic profiling of renal cell carcinoma: High-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis

“…Alterations in blood lipid metabolism have been found in patients with thyroid [24] and other cancers [25,26]. The significant increase in the serum lipid concentration and concomitant decrease in the PCho/choline concentration we observed in RCC patients are consistent with those reported in an earlier study of RCC tissue [17].…”

“…It has become the most prevalent malignancy of the kidney and accounts for about 3% of all adult cancers in western countries [1,2]. A favorable prognosis (95% at 5 years) can be obtained by radical nephrectomy with [26]. b The average age (mean ± S.D.…”

Lipid changes occuring in the course of hematological cancers

“…In a study involving 43 patients with multiple myeloma, Hachem et al [15] demonstrated a decrease in HDL-C, LDL-C and TC levels compared to the control group. Kuliszkiewicz-Janus et al [16] observed a significant decrease on HDL-C, LDL-C and TC cholesterol concentrations in patients with newly diagnosed multiple myeloma, which seemed to normalize in the remission period. In this study, however, the changes in the lipid fractions in these patients were less pronounced and limited to the HDL-C level.…”

Application of 31P NMR spectroscopy to monitor chemotherapy‐associated changes of serum phospholipids in patients with malignant lymphomas

“…Correlation between the concentrations of lipids and lipoprotein concentrations and intensities of PL in the NMR spectra were assessed by calculating the correlation coefficient. (13) and our own studies (14,15) have shown the 31P MRS spectra of normal sera to consist of three peaks: a downfield peak due to inorganic phosphate and two additional upfield peaks (Figs. l a and Ib).…”